Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Leukapheresis Market Size, Value And Growth Trajectory Through 2030
The leukapheresis market has experienced robust expansion in recent years. It is projected to increase from $72.02 billion in 2025 to $77.7 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.9%. The historical growth of this market can be attributed to several factors, including a rise in hematologic disorders, the broadening of cancer research programs, increased utilization of apheresis in blood centers, advancements in centrifugation technologies, and a surge in clinical research funding.
The leukapheresis market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $104.27 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.6%. This projected growth can be ascribed to several factors, including the expansion of CAR-T and other cell-based therapies, heightened investment in immunology research, a growing need for personalized medicine, the enlargement of biopharmaceutical manufacturing capabilities, and improvements in apheresis automation technology. Key developments expected during this period involve the increasing application of leukapheresis in cell and gene therapies, a greater requirement for immune cell collection in oncology, the wider implementation of automated apheresis systems, the broader integration of leukapheresis into clinical research, and an intensified emphasis on patient-safe disposable apheresis kits.
Get A Free Sample Report With In-Depth Market Insights:
Leukapheresis Market Demand Drivers: What’s Powering Industry Growth?
The increasing incidence of autoimmune diseases is projected to drive the expansion of the leukapheresis market in the future. These conditions are characterized by the immune system erroneously targeting and damaging the body’s healthy tissues. Factors such as decreased microbial exposure in early life and contemporary environmental influences are disturbing immune equilibrium, contributing to an increase in autoimmune disorders. Leukapheresis offers a therapeutic approach for autoimmune diseases through the selective extraction of detrimental white blood cells responsible for the immune system’s assault on the body’s intrinsic tissues. For example, data from September 2025, provided by GetValue.co, a US-based online digital platform, indicates that autoimmune diseases impact an estimated 3–10% of the worldwide population, which corresponds to approximately 600–800 million individuals globally. Consequently, the growing prevalence of autoimmune diseases is a key factor boosting the growth of the leukapheresis market.
Leukapheresis Market Segment Analysis: What Are The Core Market Categories?
The leukapheresis market covered in this report is segmented –
1) By Apheresis Type: Granulocyte Apheresis, Lymphocyte Apheresis, Monocyte Apheresis
2) By Product: Leukapheresis Devices, Centrifugal Devices, Membrane Separators, Leukapheresis Disposables
3) By Application: Research Application, Cancer Research, Immunology Research, Therapeutics Application, Hematologic Disorders, Autoimmune Diseases, Other Applications
4) By End User: Blood Component Providers And Blood Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Transfusion Centers
Subsegments:
1) By Granulocyte Apheresis: Neutrophil Apheresis, Eosinophil Apheresis, Basophil Apheresis
2) By Lymphocyte Apheresis: T-Cell Apheresis, B-Cell Apheresis, Natural Killer (NK) Cell Apheresis
3) By Monocyte Apheresis: Classical Monocytes, Non-Classical Monocytes, Intermediate Monocytes
Leukapheresis Market Innovation Trends: What Developments Are Reshaping The Industry?
Leading companies operating within the leukapheresis market are concentrating on advancements, including the development of GMP-grade leukopaks, to improve the quality and efficiency of manufacturing for cell therapies. GMP-grade leukopaks represent products derived from leukapheresis, processed under rigorous good manufacturing practice (GMP) standards, which guarantees the high viability and functionality of the collected cells for their therapeutic uses. For instance, in November 2024, Sanguine Biosciences, a US-based biotechnology company, launched LeukoCer, a GMP-grade leukopak designed to optimize workflows and accelerate the development of cell therapies. LeukoCert delivers high-quality starting materials, offered in fresh whole or half packs, produced according to strict GMP standards, thereby empowering researchers to further their research and introduce new cell therapies to the market at a faster pace.
Leukapheresis Market Top Companies Driving Competitive Growth
Major companies operating in the leukapheresis market are Fresenius Kabi, Grifols S.A., Terumo BCT Inc., Nikkiso Co., Haemonetics Corporation, Macopharma, MEDICA S.p.A, Caltag Medsystems Ltd., Miltenyi Biotec, Puriblood Medical, Cytopheron Technologies, STEMCELL Technologies Inc., Discovery Life Sciences, BioIVT LLC, StemExpress LLC, AllCells LLC, HemaCare Corporation, Key Biologics LLC, Immune Therapy Holdings AB, Cellsep Laboratories
View The Full Leukapheresis Market Report:
Leukapheresis Market Geographic Analysis: Where Is Demand Accelerating Fastest?
North America was the largest region in the leukapheresis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leukapheresis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
